Lead sponsor
AZTherapies, Inc.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
676
Total enrollment
122
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Phase 3
1
Trials by status
Completed
2
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteersmild-to-moderate ADPh 1Completed56
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)Study partner/caregiver requiredPh 2Withdrawnnot disclosed